26 noviembre 2014
Scientists analyzed tissue samples from patients who had — and had not — responded to a promising new immunotherapy drug. The study could help identify patients most likely to respond to the new drug, which blocks PD-L1.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/zfEsq57cLlI/141126133825.htm
